132 related articles for article (PubMed ID: 32427927)
1. Thymic resident NKT cell subsets show differential requirements for CD28 co-stimulation during antigenic activation.
Shissler SC; Singh NJ; Webb TJ
Sci Rep; 2020 May; 10(1):8218. PubMed ID: 32427927
[TBL] [Abstract][Full Text] [Related]
2. Innate NKTγδ and NKTαβ cells exert similar functions and compete for a thymic niche.
Pereira P; Boucontet L
Eur J Immunol; 2012 May; 42(5):1272-81. PubMed ID: 22539299
[TBL] [Abstract][Full Text] [Related]
3. Control of NKT cell differentiation by tissue-specific microenvironments.
Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
[TBL] [Abstract][Full Text] [Related]
4. γδ T cells acquire effector fates in the thymus and differentiate into cytokine-producing effectors in a Listeria model of infection independently of CD28 costimulation.
Laird RM; Wolf BJ; Princiotta MF; Hayes SM
PLoS One; 2013; 8(5):e63178. PubMed ID: 23671671
[TBL] [Abstract][Full Text] [Related]
5. Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway.
Williams JA; Lumsden JM; Yu X; Feigenbaum L; Zhang J; Steinberg SM; Hodes RJ
J Immunol; 2008 Jul; 181(2):907-17. PubMed ID: 18606642
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development.
Sandrock I; Ziętara N; Łyszkiewicz M; Oberdörfer L; Witzlau K; Krueger A; Prinz I
PLoS One; 2015; 10(12):e0145010. PubMed ID: 26673421
[TBL] [Abstract][Full Text] [Related]
7. CD28 controls the development of innate-like CD8+ T cells by promoting the functional maturation of NKT cells.
Yousefi M; Duplay P
Eur J Immunol; 2013 Nov; 43(11):3017-27. PubMed ID: 23896981
[TBL] [Abstract][Full Text] [Related]
8. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells.
Germanov E; Veinotte L; Cullen R; Chamberlain E; Butcher EC; Johnston B
J Immunol; 2008 Jul; 181(1):81-91. PubMed ID: 18566372
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Thymic Development of Natural Killer T Cell Subsets by Multiparameter Flow Cytometry.
Tuttle KD; Gapin L
Methods Mol Biol; 2018; 1799():121-133. PubMed ID: 29956149
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
[TBL] [Abstract][Full Text] [Related]
11. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
12. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
Stenström M; Sköld M; Andersson A; Cardell SL
Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
[TBL] [Abstract][Full Text] [Related]
13. Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation.
Michel ML; Mendes-da-Cruz D; Keller AC; Lochner M; Schneider E; Dy M; Eberl G; Leite-de-Moraes MC
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19845-50. PubMed ID: 19057011
[TBL] [Abstract][Full Text] [Related]
14. Expansion and CD2/CD3/CD28 stimulation enhance Th2 cytokine secretion of human invariant NKT cells with retained anti-tumor cytotoxicity.
Andrews K; Hamers AAJ; Sun X; Neale G; Verbist K; Tedrick P; Nichols KE; Pereira S; Geraghty DE; Pillai AB
Cytotherapy; 2020 May; 22(5):276-290. PubMed ID: 32238299
[TBL] [Abstract][Full Text] [Related]
15. Modulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation.
Zheng X; Zhang H; Yin L; Wang CR; Liu Y; Zheng P
PLoS One; 2008 Jul; 3(7):e2703. PubMed ID: 18628995
[TBL] [Abstract][Full Text] [Related]
16. [Study of the NKT cell subsets with superantigen SEB-activated tolerance].
Chen Y; Zhong J; Xu J; Chen ZC; Guo YL; Jin T; Zhang JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):943-6. PubMed ID: 18845074
[TBL] [Abstract][Full Text] [Related]
17. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
Pellicci DG; Hammond KJ; Uldrich AP; Baxter AG; Smyth MJ; Godfrey DI
J Exp Med; 2002 Apr; 195(7):835-44. PubMed ID: 11927628
[TBL] [Abstract][Full Text] [Related]
18. Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.
Noma H; Eshima K; Satoh M; Iwabuchi K
Immunology; 2015 Sep; 146(1):89-99. PubMed ID: 25988531
[TBL] [Abstract][Full Text] [Related]
19. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
[TBL] [Abstract][Full Text] [Related]
20. Pak2 Controls Acquisition of NKT Cell Fate by Regulating Expression of the Transcription Factors PLZF and Egr2.
O'Hagan KL; Zhao J; Pryshchep O; Wang CR; Phee H
J Immunol; 2015 Dec; 195(11):5272-84. PubMed ID: 26519537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
